Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.
2010-12-29
Registered
14F7 MAb marked with Tc99 Phase II in breast tumors.
2010-12-29
Registered
T1h in severe psoriasis-expanded access program (PUCE)
2012-07-20
Registered
EGF-based vaccine with VChTV Schedule in hormone-refractory prostate tumors
2013-06-19
Registered
EGF vaccine- Advanced Lung tumors
2013-06-20
Registered
Post EUA study of Itolizumab in COVID-19
21/03/2022
Registered outdated
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX
21/05/2021
Registered outdated
Nimotuzumab in COVID-19
21/05/2021
Registered
VSSPs in renal carcinoma.
21/06/2023
Registered
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II
22/04/2016
Registered
Itolizumab for Relapsing Remitting Multiple Sclerosis
22/05/2015
Registered
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations
22/05/2021
Registered outdated
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant
22/09/2022
Registered
CIMAvax-EGF in patients at high risk of lung cancer
22/10/2020
Registered outdated
hR3 in metastatic or recurrent colorectal cancer
22/11/2013
Registered
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer.
23/05/2014
Registered
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus
23/12/2016
Registered
Itolizumab Safety and Efficacy Study in Covid 19
26/03/2021
Registered
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer.
26/05/2014
Registered
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer
28/11/2016
Registered
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform